These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 19110320

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia.
    Dong E, Agis-Balboa RC, Simonini MV, Grayson DR, Costa E, Guidotti A.
    Proc Natl Acad Sci U S A; 2005 Aug 30; 102(35):12578-83. PubMed ID: 16113080
    [Abstract] [Full Text] [Related]

  • 6. Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation.
    Dong E, Nelson M, Grayson DR, Costa E, Guidotti A.
    Proc Natl Acad Sci U S A; 2008 Sep 09; 105(36):13614-9. PubMed ID: 18757738
    [Abstract] [Full Text] [Related]

  • 7. Epigenetic downregulation of GABAergic function in schizophrenia: potential for pharmacological intervention?
    Costa E, Grayson DR, Guidotti A.
    Mol Interv; 2003 Jun 09; 3(4):220-9. PubMed ID: 14993449
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Histone deacetylase inhibitors decrease reelin promoter methylation in vitro.
    Mitchell CP, Chen Y, Kundakovic M, Costa E, Grayson DR.
    J Neurochem; 2005 Apr 09; 93(2):483-92. PubMed ID: 15816871
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. DNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients.
    Dong E, Ruzicka WB, Grayson DR, Guidotti A.
    Schizophr Res; 2015 Sep 09; 167(1-3):35-41. PubMed ID: 25476119
    [Abstract] [Full Text] [Related]

  • 16. Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability.
    Costa E, Davis J, Grayson DR, Guidotti A, Pappas GD, Pesold C.
    Neurobiol Dis; 2001 Oct 09; 8(5):723-42. PubMed ID: 11592844
    [Abstract] [Full Text] [Related]

  • 17. Region-specific alteration of GABAergic markers in the brain of heterozygous reeler mice.
    Nullmeier S, Panther P, Dobrowolny H, Frotscher M, Zhao S, Schwegler H, Wolf R.
    Eur J Neurosci; 2011 Feb 09; 33(4):689-98. PubMed ID: 21226776
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon.
    Guidotti A, Auta J, Davis JM, Dong E, Grayson DR, Veldic M, Zhang X, Costa E.
    Psychopharmacology (Berl); 2005 Jul 09; 180(2):191-205. PubMed ID: 15864560
    [Abstract] [Full Text] [Related]

  • 20. The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes.
    Kundakovic M, Chen Y, Guidotti A, Grayson DR.
    Mol Pharmacol; 2009 Feb 09; 75(2):342-54. PubMed ID: 19029285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.